We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Community-Based Interventions for Infant Health in Nepal

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00656591
Recruitment Status : Unknown
Verified April 2008 by Institute of Child Health.
Recruitment status was:  Recruiting
First Posted : April 11, 2008
Last Update Posted : April 11, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal & Infant Mortality and to Improve Fetal Growth & Cognitive Development in Infancy

Condition or disease Intervention/treatment Phase
Child Mortality Drug: Methotrexate Phase 1

Study Design

Study Type : Observational
Estimated Enrollment : 192000 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal and Infant Mortality, and to Improve Fetal Growth and Cognitive Development in Infancy.
Study Start Date : March 2005
Estimated Primary Completion Date : December 2008
Estimated Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Intervention Details:
    Drug: Methotrexate
    Methotrexate

Outcome Measures

Primary Outcome Measures :
  1. neonatal mortality rates [ Time Frame: 2 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
48 village development committee areas
Criteria

Inclusion Criteria:

  • mothers, community health volunteers

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00656591


Locations
United Kingdom
International Child Health, ICH Recruiting
London, United Kingdom, WC1N 1EH
Contact: Anthony Costello, Dr       a.costello@ich.ucl.ac.uk   
Sponsors and Collaborators
Institute of Child Health
Investigators
Principal Investigator: Anthony Costello, Dr Institute of Child Health
More Information

Responsible Party: R&D Office, Institute of Child Health
ClinicalTrials.gov Identifier: NCT00656591     History of Changes
Other Study ID Numbers: 04PC01
First Posted: April 11, 2008    Key Record Dates
Last Update Posted: April 11, 2008
Last Verified: April 2008

Keywords provided by Institute of Child Health:
Child mortality, Nepal, Community, care practices

Additional relevant MeSH terms:
Methotrexate
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Antimetabolites, Antineoplastic
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunosuppressive Agents
Immunologic Factors
Antirheumatic Agents
Nucleic Acid Synthesis Inhibitors